ATAaron P. Thrift

Aaron P. Thrift

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aaron P. Thrift has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • External Validation of the Michigan Barrett's Esophagus Prediction Tool (M-Beret)

    by Aaron P. Thrift, Thomas Vaughan, Lesley A. Anderson, David Whiteman, Hashem B. El-Serag


  • Tu1129 Gluteofemoral Obesity Is Associated With a Reduced Risk of Barrett's Esophagus in Men: A Pooled Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium

    by Bradley J. Kendall, Joel Rubenstein, Michael B. Cook, Thomas Vaughan, Lesley A. Anderson, Liam J. Murray, Nicholas Shaheen, Douglas Corley, Hashem B. El-Serag, David C. Whiteman, et al.

  • Open Access

    Tu1770 Obstructive Sleep Apnea, Gastroesophageal Reflux and Barrett's Esophagus in a Population-Based Case-Control Study

    by Anna P. Lindam, Bradley J. Kendall, Aaron P. Thrift, Graeme A. Macdonald, Jesper Lagergren, David C. Whiteman, Yilang Tang, Sonja Reissig, Elke Glasmacher, Tommy Regen, et al.

  • A Model to Determine Absolute Risk for Esophageal Adenocarcinoma

    by Aaron P. Thrift, Bradley J. Kendall, Nirmala Pandeya, David C. Whiteman


  • A Clinical Risk Prediction Model for Barrett Esophagus

    by Aaron P. Thrift, Bradley J. Kendall, Nirmala Pandeya, Thomas L. Vaughan, David C. Whiteman, for the Study of Digestive Health

    Barrett esophagus is the only known precursor to esophageal adenocarcinoma. As definitive diagnosis requires costly endoscopic investigation, we sought to develop a risk prediction model to aid in deciding which patients with gastroesophageal reflux symptoms to refer for endoscopic screening for Barrett esophagus. The study included data from patients with incident nondysplastic Barrett esophagus (n = 285) and endoscopy control patients with esophageal inflammatory changes without Barrett esophagus (“inflammation controls”, n = 313). We used two phases of stepwise backwards logistic regression to identify the important predictors for Barrett esophagus in men and women separately: first, including all significant covariates from univariate analyses and then fitting non-significant covariates from univariate analyses to identify those effects detectable only after adjusting for other factors. The final model pooled these predictors and was externally validated for discrimination and calibration using data from a Barrett esophagus study conducted in western Washington State. The final risk model included terms for age, sex, smoking status, body mass index, highest level of education, and frequency of use of acid suppressant medications (area under the ROC curve, 0.70; 95%CI, 0.66–0.74). The model had moderate discrimination in the external dataset (area under the ROC curve, 0.61; 95%CI, 0.56–0.66). The model was well calibrated (Hosmer–Lemeshow test, P = 0.75), with predicted probability and observed risk highly correlated. The prediction model performed reasonably well and has the potential to be an effective and useful clinical tool in selecting patients with gastroesophageal reflux symptoms to refer for endoscopic screening for Barrett esophagus. Cancer Prev Res; 5(9); 1115–23. ©2012 AACR.


  • Top Cited Papers
    Open Access

    The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends

    by A. P. Thrift, D. C. Whiteman

    During the past four decades, the incidence of esophageal adenocarcinoma (EAC) has increased markedly in Western populations. Recent reports have suggested that the rate of increase has slowed or plateaued. Using data from cancer registries in Australia, the United States and Sweden, we examined incidence trends for esophageal and gastric cardia tumors between 1984 and 2008 using joinpoint analyses and age–period–cohort models. EAC incidence continues to undergo statistically significant annual increases in Australia and the United States, although the rate of increase has slowed. Among men, incidence increased annually by 2.2% [95% confidence interval (CI) 1.5% to 2.9%] between 1994 and 2008 in Australia and 1.5% (95% CI 0.2% to 2.8%) between 1998 and 2008 in the United States. EAC incidence among men remained unchanged in Sweden between 2001 and 2008 (P = 0.52). EAC incidence among women showed significant linear increases between 1984 and 2008. Age–period–cohort models suggested strong effects for both period and birth cohort on EAC incidence in Australia and the United States, and a strong period effect for Sweden. EAC incidence continues to increase in Australia and the United States. The continued increases, even among more recent birth cohorts, suggest that EAC incidence will continue to rise during coming decades.


  • Open Access

    A 5-year longitudinal study of schistosomiasis transmission in Shian village, the Anning River Valley, Sichuan Province, the Peoples' Republic of China

    by Rong Zhu, Darren J Gray, Aaron P Thrift, Gail M Williams, Yi Zhang, Dong-Chuan Qiu, Feng Zheng, Yue-Sheng Li, Jiagang Guo, Hong-Qing Zhu, et al.

    Background: Schistosoma japonicum is a major public health concern in the Peoples' Republic of China (PRC), with over one million people infected and another 50 million living in areas at risk of infection. Based on ecological, environmental, population genetic and molecular factors, schistosomiasis transmission in PRC can be categorised into four discrete ecosystems or transmission modes. It is predicted that the Three Gorges Dam (TGD) will impact upon the transmission of schistosomiasis in the PRC, with varying degree across the four transmission modes. We undertook longitudinal surveillance from 2002 to 2006 in sentinel villages both above and below the TGD across five provinces (Hunan, Jiangxi, Hubei, Anhui and Sichuan) to determine whether there was any impact of the TGD on schistosomiasis transmission during its construction. Here we present the results from a schistosomiasis-endemic village located above the dam in Sichuan Province. Results: Baseline results showed a human S. japonicum prevalence of 42.0% (95% CI: 36.6-47.5). At follow-up, results showed that the incidence of S. japonicum infection in the selected human cohort in Shian decreased by three quarters from 46% in 2003 to 11.3% in 2006. A significant (P < 0.01) downward trend was also evident in the yearly adjusted (for water contact) odds ratios. Over the four years of follow-up, the incidence of S. japonicum infection in bovines declined from 11.8% in the first year to zero in the final year of follow-up. Conclusions: The substantial decrease in human (75%) and bovine (100%) incidence observed in Shian village can probably be attributed to the annual human and bovine PZQ treatment of positives; as seen in drug (PZQ) intervention studies in other parts of PRC. If an increase in schistosome transmission had occurred as a result of the TGD, it would be of negligible size compared to the treatment induced decline seen here. It appears therefore that the construction of the TGD had virtually no impact on schistosomiasis transmission in Shian village over the period of study. Furthermore, contrary to previous reports from Sichuan downplaying the role of animals in human schistosome transmission, bovines may indeed play a role.